The free dividend tracker to help you grow your wealth. Link your brokerage accounts and MerryDiv automatically syncs your holdings and dividends.
Data last updated: Oct 16, 2026
Snapshot (as of Oct 16, 2026): Becton, Dickinson and Company (BDX) pays a $4.19 annual dividend ($1.05 quarterly), yielding 2.17% at $190.89/share. Next ex-dividend date 2026-09-09. 42+ consecutive years of dividend growth (Dividend Aristocrat). Source: Yahoo Finance, aggregated by MerryDiv.
Dividend Yield: 2.17%
Annual Dividend: $4.19 per share
Payout Ratio: 72.5%
Ex-Dividend Date: 2026-09-09
Dividend Frequency: quarterly
Sector: Healthcare
Years of Dividend History: 45
Becton, Dickinson and Company dividend investors are looking at a healthcare giant that manufactures medical supplies, diagnostic products, and drug delivery systems used by hospitals and clinical laboratories worldwide. BDX currently yields 2.29%, with trailing twelve-month payments of $4.19 per share paid quarterly. The next ex-dividend date is September 9, 2026, with the last declared quarterly payment at $1.05 per share. A Dividend Aristocrat with 42 consecutive years of increases, BDX stock suits income investors who value low volatility, with a beta of just 0.279.
Becton, Dickinson and Company pays out 72.5% of earnings as dividends, a payout ratio classified as elevated (60–75%). Becton, Dickinson and Company dividend safety draws support from the company's position supplying essential, non-discretionary products: peripheral IV catheters, hypodermic syringes, specimen collection systems, and automated medication dispensing equipment that healthcare institutions depend on regardless of economic conditions. The primary pressure point is that a 72.5% payout leaves limited room to absorb earnings weakness without squeezing future increases.
Becton, Dickinson and Company dividend history shows a CAGR of 7.4% per year from 2011 to 2025. Per-share payments grew from $1.29 to $3.50 over that window (2026 data is partial and excluded from the rate calculation). The smallest annual increase in the window was 2.7% in 2018, while the largest reached 12.7% in 2024, showing the pace of growth is not uniform year to year.
| Period | CAGR | From | To |
|---|---|---|---|
| 3-Year | +8.4% | $2.75 (2022) | $3.50 (2025) |
| 5-Year | +7.4% | $2.45 (2020) | $3.50 (2025) |
| 10-Year | +6.4% | $1.89 (2015) | $3.50 (2025) |
BDX fits dividend investors who prioritize low volatility and a long, unbroken increase streak over maximum current income. The yield sits at a moderate (2–4%) 2.29%, above the stock's own 5-year average of 1.65%, which means today's entry point delivers more income than the historical norm. Forty-two consecutive years of increases confirm Dividend Aristocrat status, a rare distinction that reflects the durability of BDX's medical supply and diagnostics business. The trade-off is a payout ratio at 72.5%, which is elevated and narrows the buffer for future increases if earnings come under pressure.
BDX is a Dividend Aristocrat with 42 consecutive years of dividend increases.
| Payment Date | Amount per Share |
|---|---|
| 2026-09-09 | $1.0500 |
| 2026-06-09 | $1.0500 |
| 2026-03-10 | $1.0500 |
| 2025-12-08 | $0.8252 |
| 2025-09-08 | $0.8176 |
| 2025-06-09 | $0.8173 |
| 2025-03-10 | $1.0400 |
| 2024-12-09 | $0.8176 |
| 2024-09-09 | $0.9500 |
| 2024-06-10 | $0.7469 |
| Year | Total Dividends |
|---|---|
| 2026 | $3.1500 |
| 2025 | $3.5000 |
| 2024 | $3.2614 |
| 2023 | $2.8931 |
| 2022 | $2.7507 |
Project income from BDX with the BDX dividend calculator or track your full portfolio with the dividend tracker.